How many longevity clinics are there in South Korea?
The Atlas records 5 longevity and
preventive clinics in South Korea.
Across all four pillars of the healthspan economy it
records 8 organizations in South Korea, broken down below.
The Healthspan Economy Atlas records 8 organizations in South Korea.
Counted from published rows only. Closed and not-yet-open organizations, and
duplicate listings, are excluded. Fertility clinics and pure booking or
telehealth platforms are mapped in the Atlas but held out of this count.
- 5
- South Korea has 5 longevity and preventive medicine organizations in the Atlas.
- 1
- South Korea has 1 femtech and women's health organization in the Atlas, too few yet to read as a concentration.
- 1
- South Korea has 1 integrative and functional medicine organization in the Atlas, too few yet to read as a concentration.
- 1
- South Korea has 1 healthtech and diagnostics organization in the Atlas, too few yet to read as a concentration.
Verified: 2 of 5 clinics, most recent check September 29, 2026.
Where are they concentrated in South Korea?
The Atlas records these city concentrations in South Korea, each with
three or more organizations holding a recorded site in the city.
A further 3 organizations hold
no recorded site in any city listed above, whether because the site
is in a smaller city in South Korea or because no site is on record.
Counted for the country, not shown as a concentration.
How is longevity medicine regulated in South Korea?
South Korea classifies every medical institution into three tiers and, since a 2024 amendment reported to take effect in 2025, lets designated institutions provide advanced regenerative therapy as billable care. The amendment's details rest on non-primary text. No tier is specific to longevity.
- No dedicated longevity category exists. Medical institutions fall into three tiers.
- Ministry of Health and Welfare, Medical Service Act, as checked July 2026.
Primary source.
- The Advanced Regenerative Bio Act originally confined advanced regenerative medicine largely to clinical research that patients could not be charged for.
- Ministry of Food and Drug Safety; Ministry of Health and Welfare, Advanced Regenerative Bio Act (Act No. 16556 of 2019), in force August 28, 2020.
Primary source.
- A 2024 amendment is reported to create a category of advanced regenerative medicine treatment that lets designated institutions provide the therapy as billable care to patients with serious, rare or incurable conditions. The official English text had not published at the time of the check, so the effective date, the article numbers and the approval term rest on non-primary sources and should be confirmed against the Korean original.
- Ministry of Health and Welfare; Ministry of Food and Drug Safety, 2024 amendment to the Advanced Regenerative Bio Act, reported effective, unconfirmed February 2025.
Primary source.
- Direct-to-consumer genetic testing is permitted only within a certified list of items.
- Ministry of Health and Welfare, Bioethics and Safety Act, as checked July 2026.
Primary source.
Medium confidence, driven by the 2024 amendment. Its effective date, article numbers and approval term rest on non-primary text because the official English translation had not published, and are flagged in the amendment entry above.
For how South Korea compares with other markets, see Longevity Clinic Regulation, Market by Market.